Increased level of serum Homocysteine in vitiligo

Background: Vitiligo is an acquired depigmenting disorder caused by the destruction of melanocytes. The exact etiopathogenesis and mechanisms of vitiligo are not fully understood. Vitamin B12 and folic acid levels are decreased in vitiligo, which are the important cofactors required in the metabolism of Homocysteine (Hcy). Consequently, Hcy level increases in the circulation. Therefore, it is possible that increased Hcy plays a role in melanocytes destruction. The aim was to study for any association of vitiligo with serum Hcy level. Method: A total of 30 vitiligo patients of both sexes and 30 control subjects were enrolled in this study. Sera from patients and controls were assayed for Hcy by Enzyme immunoassay. The collected data were analyzed by SPSS version‐16. Results: The mean serum level of Hcy was significantly higher in patients with vitiligo as compared with healthy controls and its level was high in male patients as compared with female patients. The Hcy level in vegetarian patients was significantly higher as compared with nonvegetarian patients. The Hcy level was also significantly higher in active vitiligo patients as compared with stable vitiligo patients. Conclusion: An increased serum Hcy may be a precipitating factor for vitiligo in the predisposed individuals. Serum Hcy is related to the gender of patients, activity of disease, and dietary habits of vitiligo patients. J. Clin. Lab. Anal. 25:110–112, 2011. © 2011 Wiley‐Liss, Inc.

[1]  D. Balcı,et al.  Serum homocysteine, folic acid and vitamin B12 levels in vitiligo. , 2009, European journal of dermatology : EJD.

[2]  O. Shaker,et al.  Is there a relationship between homocysteine and vitiligo? A pilot study , 2008, The British journal of dermatology.

[3]  J. Kalita,et al.  A study of homocysteine level in North Indian subjects with special reference to their dietary habit , 2007 .

[4]  R. Boissy,et al.  A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo. , 2006, The American journal of pathology.

[5]  Daowen Wang,et al.  [Study on the distribution of serum homocysteine and on multi-stepwise regression analysis of the associated factors in the population of community areas in Wuhan]. , 2004, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[6]  Z. Bobby,et al.  High Frequency Of Thyroid Dysfunction In Indian Patients With Vitiligo , 2003 .

[7]  P. Galan,et al.  [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data]. , 2003, Pathologie-biologie.

[8]  H. Wieland,et al.  Assessment of vitamin B-12, folate, and vitamin B-6 status and relation to sulfur amino acid metabolism in neonates. , 2000, The American journal of clinical nutrition.

[9]  K. Robinson Homocysteine, B vitamins, and risk of cardiovascular disease , 2000, Heart.

[10]  S. Hann,et al.  Serum levels of folic acid and vitamin B12 in Korean patients with vitiligo. , 1999, Yonsei medical journal.

[11]  M. Kim,et al.  Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia. , 1997, Metabolism: clinical and experimental.

[12]  P. Fishman,et al.  Tyrosinase as an autoantigen in patients with vitiligo , 1996, Clinical and experimental immunology.

[13]  P. Ueland,et al.  Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. , 1996, The American journal of clinical nutrition.

[14]  R. King,et al.  Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency. , 1995, American journal of human genetics.

[15]  L. Montes,et al.  Folic acid and vitamin B12 in vitiligo: a nutritional approach. , 1992, Cutis.

[16]  S. Mudd Disorders of transsulfuration , 1989 .